Genzyme Corporation

Genzyme Corporation (United States) holds 0 active US FDA Type II Drug Master Files and 8 inactive, has DMF or CEP filings on record for 3 active ingredients and is linked to 4 FDA-registered manufacturing sites. 20 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Genzyme Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/genzyme-corporation

Overview

Genzyme Corporation is a biotechnology company dedicated to discovering and delivering transformative therapies for patients with rare and ultra-rare diseases. As a subsidiary of Sanofi, Genzyme focuses on developing therapies that can address unmet medical needs in several therapeutic areas.

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Genzyme Corporation holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Genzyme Corporation holds 0 active (8 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LEUPROLIDE ACETATEInactive1999-10-08
  • CLINDAMYCIN PHOSPHATEInactive1998-09-01
  • 5-METHYLSULFONAMIDOINDOLE-2-CARBOXYLIC ACIDInactive1994-07-21
  • SN-1-PALMITOYL-2-OLEOYLPHOSPHATIDYLGLYCEROL SODIUM SALT (POPG.NA)Inactive1994-05-25
  • SODIUM CHOLESTERYL SULPHATEInactive1993-09-30
  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN LIESTAL, SWITZERLAND.Inactive1993-07-26
  • CERAMIDETRIHEXOSIDASEInactive1993-02-25
  • ACEBUTOLOL HYDROCHLORIDEInactive1992-11-10

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to Genzyme Corporation, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

20 FDA enforcement records linked to this company.

  • 4832025-02-14

    No written record of investigation

  • 4832025-02-14

    Examination of packaging and labeling

  • 4832025-02-14

    Procedures are written, and followed

  • warning_letter2025-01-15

    FDA Warning Letter (drug product)

  • recall — Class III2017-11-22

    Labeling: Incorrect or Missing Package Insert.

  • 4832016-08-18

    Deviations from laboratory control requirements

  • 4832016-08-18

    Calibration/Inspection/Checking not done

  • 4832016-08-18

    No written record of investigation

  • recall — Class III2016-04-06

    Labeling: Incorrect or Missing Lot and/or Exp Date

  • recall — Class II2016-03-09

    Presence of Particulate Matter: Glass particles found in the product after reconstitution.

  • recall — Class II2016-03-09

    Presence of Particulate Matter: Glass particles found in the product after reconstitution.

  • 4832014-11-21

    Contract drug products--lack of responsibility

  • 4832014-11-21

    Contamination, chemical or physical change, deterioration

  • 4832011-06-28

    Investigations of discrepancies, failures

  • 4832011-06-28

    Test methods

  • 4832010-06-02

    Late submission of annual safety reports

  • 4832010-06-02

    Submission of report follow-up

  • 4832010-06-02

    Failure to meet specifications

  • 4832010-06-02

    Late submission of 15-day report

  • 4832010-06-02

    Failure by applicant to report ADE

For suppliers

Is this Genzyme Corporation?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.